Business
Biophytis S A : and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
Biophytis S A : and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in
About this update from Biophytis Sa
13 Oct 2025 07:00 CEST Subscribe Issuer BIOPHYTIS See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo 16165_1363583_PR_JV_Biophytis_x_Consortium_13102025_VDEF.pdf Source Biophytis Provider Les Echos Company Name BIOPHYTIS ISIN FR001400OLP5 Symbol ALBPS Market Euronext Growth